PROBLEM TO BE SOLVED: To establish a therapeutic technology for alleviating an ischemia reperfusion injury that has a low risk of side effects and is capable of suppressing neutrophil infiltration and platelet activation during ischemia reperfusion.SOLUTION: An inhalable medical gaseous composition of the present invention which contains oxygen, hydrogen, and nitric oxide, and the remainder consisting of inert gas is an inhalable medical gaseous composition for alleviating an ischemia-reperfusion injury. In the composition, the oxygen concentration is 21-98%, the hydrogen concentration is 0.1-4%, and the nitric monoxide concentration is 20-40 ppm.COPYRIGHT: (C)2014,JPO&INPIT【課題】副作用の危険性が少なく、虚血再灌流時の好中球の浸潤や血小板活性化も抑制可能な、虚血再灌流障害の軽減のための治療技術を確立する。【解決手段】本発明の吸入用気体状薬剤組成物は、酸素、水素、一酸化窒素を含有し、残部が不活性ガスからなる、虚血再灌流障害を軽減するための吸入用気体状薬剤組成物であって、前記組成物中の酸素濃度が21~98%、水素濃度が0.1~4%、一酸化窒素濃度が20~40ppm未満であることを特徴とする。【選択図】図4
